New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Relay Therapeutics, Inc.
RLAY
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

670M

Biotechnology

Next Earning date - 27 Feb 2025

670M

Biotechnology

Next Earning date - 27 Feb 2025

4.00USD

Shape0.04 ( 1.01%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

-52%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

64%

Quote Panel

Shape
Updated February 17, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

RLAY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4M

ShapeNaN%

2025-Revenue

$2.64

Shape-319%

2025-EPS

$2M

Shape98%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Oppenheimer

downgrade

Previous: Buy

2024-09-09

Now: Perform

Citigroup

upgrade

Previous: Buy

2023-04-20

Now: Overweight

Piper Sandler

downgrade

Previous: Not converted

2023-04-20

Now: Neutral

Wolfe Research

downgrade

Previous: Not converted

2023-04-20

Now: Underperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.56
vs 0.36

Q1.23

arrow
arrow

N/A

-0.78
vs -0.61

Q2.23

arrow
arrow

N/A

-0.81
vs -0.71

Q3.23

arrow
arrow

N/A

-0.54
vs -0.76

Q4.23

arrow
arrow

N/A

-0.67
vs -0.56

Q1.24

arrow
arrow

N/A

-0.62
vs -0.78

Q2.24

arrow
arrow

N/A

-0.69
vs -0.81

Q3.24

arrow
arrow

N/A

-0.63
vs -0.54

Q4.24

arrow
arrow

N/A

-0.57
vs -0.67

Q1.25

arrow
arrow

N/A

-0.60
vs -0.62

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-55%

253K  vs 567K

Q1.23

arrow
arrow

-46%

226K  vs 419K

Q2.23

arrow
arrow

-67%

119K  vs 365K

Q3.23

arrow
arrow

+7226%

25.2M  vs 344K

Q4.23

arrow
arrow

-100%

-1000.00  vs 253K

Q1.24

arrow
arrow

+4328%

10M  vs 226K

Q2.24

arrow
arrow

-100%

NA  vs 119K

Q3.24

arrow
arrow

-100%

NA  vs 25.2M

Q4.24

arrow
arrow

+675656%

6.8M  vs -1000

Q1.25

arrow
arrow

-99%

50K  vs 10M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-5%

-0.05
vs -0.09

Q1.23

arrow
arrow

-10%

-0.10
vs -0.05

Q2.23

arrow
arrow

-12%

-0.12
vs -0.10

Q3.23

arrow
arrow

-8%

-0.08
vs -0.12

Q4.23

arrow
arrow

-11%

-0.11
vs -0.08

Q1.24

arrow
arrow

-11%

-0.11
vs -0.11

Q2.24

arrow
arrow

-14%

-0.14
vs -0.11

Q3.24

arrow
arrow

-11%

-0.11
vs -0.14

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

164

164
vs 168

-2%

Q2.23

arrow
arrow

166

166
vs 164

1%

Q3.23

arrow
arrow

173

173
vs 166

4%

Q4.23

arrow
arrow

177

177
vs 173

2%

Q1.24

arrow
arrow

188

188
vs 177

6%

Q2.24

arrow
arrow

180

180
vs 188

-4%

Q3.24

arrow
arrow

199

199
vs 180

11%

Q4.24

arrow
arrow

192

192
vs 199

-4%

Earnings Growth

Latest News